SUTURING (n = 20 studies) |
SUTURING (n = 20 studies) |
SUTURING (n = 20
studies) |
SUTURING (n = 20 studies) |
SUTURING (n = 20 studies) |
SUTURING (n = 20 studies) |
SUTURING (n = 20 studies) |
SUTURING (n = 20
studies) |
SUTURING (n = 20 studies) |
Thompson et al 2013 [38] |
USA |
77 |
Randomized clinical trial |
Transoral outlet reduction (TORe) |
Minor complications |
96 |
15 |
6 |
[Jirapinyo, Kröner, Thompson, 2017
[37]
|
USA
|
252
|
Prospective study
|
Purse-string - TORe
|
Gastrointestinal bleeding and gastrojejunal stenosis (0.8%)
|
100
|
8.4
|
12
|
Jirapinyo et al 2011
[39]
|
USA
|
9
|
Matched cohort study
|
OverStitch™
|
1 stenosis, 1 emesis
|
98
|
20
|
12
|
Kumar et al 2013
[40]
|
USA
|
118
|
Prospective
|
Superficial-thickness TORe versus full-thickness TORe
|
None
|
90
|
18
|
12
|
Heylen et al 2011 [22] |
USA |
94 |
Prospective |
Over the Scope
Clip |
None |
70 |
16.5 |
6 |
Rodriguez et al 2013 [41] |
Chile |
31 |
Retrospective |
OverStitch™ |
None |
87 |
17 |
24 |
Fernández-Esparrach et al 2010 [42] |
USA |
6 |
Prospective |
EndoCinch® |
None |
95 |
35 |
19 |
Thompson et al 2006 [18] |
USA |
8 |
Prospective |
EndoCinch® |
None |
80 |
23.4 |
4 |
Thompson et al 2010 [20] |
USA |
220 |
Randomized |
EndoCinch® |
None |
89 |
60 |
6 |
Brethauer et al 2012 [45]
|
USA
|
18
|
Prospective
|
RESTORe
endoscopic suturing device
|
None
|
80
|
27.7
|
12
|
Abu Dayyeh et al 2015 [6] |
USA |
10 |
Multiple series |
OverStitch™ |
None |
90 |
30 |
6 |
Sharaiha et al 2015 [46] |
USA |
25 |
Prospective |
OverStitch™ |
None |
90 |
18.7 |
12 |
Lopez-Nava et al 2016 [47] |
Spain |
10 |
Prospective |
OverStitch™ |
None |
90 |
54 |
12 |
Lopez-Nava et al 2016 [47] |
Spain |
8 |
Prospective |
OverStitch™ |
None |
85 |
45 |
20 |
Kumar N et al 2015 [48] |
USA |
126 |
International multicenter
series |
OverStitch™ |
None |
90 |
14.5 |
6 |
Kumar N et al 2015
[48]
|
USA
|
126
|
International multicenter series
|
OverStitch™
|
None
|
90
|
19.5
|
12
|
Mikami et al 2010 [21]
|
USA
|
39
|
prospective series
|
Stomaphy X
|
Sore throat, epigastric pain
in most of the patients (76.9%)
|
87
|
19.5
|
12
|
Leitman et al 2010 [49] |
USA |
64 |
prospective series |
Stomaphy X |
2 (3%) intraoperative complications |
79 |
10 |
5.8 |
Manouchehri et al 2011 [50]
|
Canada
|
14
|
Retrospective
Study
|
Stomaphy X
|
Headache, back pain
|
100
|
11
|
6
|
Galvao Neto et al 2011 [23]
|
Brazil
|
8
|
Retrospective
Study
|
OverStitch™
|
1 hematemesis
|
50
|
28
|
3
|
SURGERY (n = 06 studies) |
SURGERY (n = 06 studies) |
SURGERY (n = 06
studies) |
SURGERY (n = 06 studies) |
SURGERY (n = 06 studies) |
SURGERY
(n = 06 studies) |
SURGERY (n = 06 studies) |
SURGERY (n = 06 studies) |
SURGERY (n = 06 studies) |
Mullady et al 2009 [51] |
USA |
20 |
prospective series |
surgery
endolumenal |
None |
60 |
7.3 |
3 |
Ryou et al 2009 [52] |
USA |
5 |
prospective series |
surgery
endolumenal |
None |
60 |
6.5 |
3 |
Horgan et al 2010 [24]
|
USA
|
116
|
prospective multicenter
series
|
surgery endolumenal
|
None
|
97
|
32
|
6
|
Thompson et al 2012 [53] |
USA |
66 |
prospective multicenter |
surgery endolumenal |
None |
97 |
14.5 |
12 |
Thompson et al 2012 [53] |
USA |
60*
|
prospective
multicenter |
surgery endolumenal |
None |
92 |
24 |
12 |
Gallo et al 2015 [43] |
|
27 |
retrospective |
surgery endolumenal |
None |
50 |
18 |
72 |
ARGON PLASMA COAGULATION (n = 08 studies) |
ARGON PLASMA COAGULATION (n
= 08 studies) |
ARGON PLASMA COAGULATION (n = 08 studies) |
ARGON PLASMA
COAGULATION (n = 08 studies) |
ARGON PLASMA COAGULATION (n = 08 studies) |
ARGON PLASMA COAGULATION (n = 08 studies) |
ARGON PLASMA COAGULATION
(n = 08 studies) |
ARGON PLASMA COAGULATION (n = 08 studies) |
ARGON
PLASMA COAGULATION (n = 08 studies) |
Cambi et al 2015 [31] |
Brazil |
49 |
Prospective |
Argon Plasma |
None |
90 |
41 |
12 |
Souza et al., 2016 [44] |
Brazil |
10 |
Cases series |
Argon Plasma |
None |
90 |
23.5 |
1 |
Baretta et al 2015 [8]
|
Brazil
|
30
|
|
Argon Plasma
|
2 severe stenosis
|
90
|
23
|
Decrease in mean
BMI and mean
diameter (P<0.05)
|
De Souza et al 2015 [30] |
Brazil |
37 |
Retrospective |
Argon
Plasma |
None |
50 |
24 |
16 |
De Quadros et al. 2020 [32] |
Brazil |
42 |
Randomized clinical
trial with crossover |
Argon Plasma |
None |
100 |
15.6 |
14 |
Moon et al. 2018 [34] |
Brazil and USA |
558 |
Multicenter
retrospective (8 centers) |
Argon Plasma |
Stenosis (n = 9), GJ ulcer (n
= 3), vomiting (n = 3), leakage of GJ (n = 2) and melena (n = 1) |
100 |
10.0 |
24 |
Jirapinyo et al. 2020 [35]
|
USA and Brazil
|
267
|
Single-centered retrospective
|
Low and high dose Argon Plasma
|
Gastrojejunal stenosis (4.6%)
|
100
|
Low
dose: 5,1
High dose: 9,7
|
12
|
Brunaldi et al., 2020 [33] |
Brazil |
40 |
Randomized clinical trial |
Argon Plasma |
Two cases of stenosis |
98 |
8.3 |
12 |